Investment

Roon Raises $15M Series A to ‘Replace Dr. Google’, Expands Women’s Health Coverage

Roon, the New York-based digital health platform aiming to replace “Dr. Google,” has secured $15 million in Series A funding. The round was co-led by FirstMark Capital and Forerunner Ventures, with participation from existing investors including Sequoia Capital and TMV. The investment values the company at $65 million pre-money. Founded in 2021 by former Pinterest executive Vikram Bhaskaran, Roon is building a…

Zarminali Health Raises $40M in Seed Funding to Build Pediatric Care Platform

Zarminali Health, a new outpatient pediatric care platform aiming to integrate primary and specialty care nationwide, has secured $40 million in seed funding led by General Catalyst. The company plans to launch its first locations still this year. The startup aims to address significant challenges in pediatric care, including fragmented services, disconnected communication between providers, and the burden of care coordination that…

Apothékary Secures $8M Pre-Series A Including Strategic Investment from Shiseido; Launches on Ulta

Apothékary, a consumer health brand focused on Japanese-inspired plant medicine, has secured an $8 million pre-Series A round, including a strategic investment from Japanese beauty giant Shiseido. The round was oversubscribed by 40% according to the company, bringing the company’s total funding to $15 million in equity and $6 million in debt funding via Walden Mutual Bank. The funding announcement coincides with…

Vitara Raises $50M to Advance Womb-Like Technology for Premature Babies

Vitara Biomedical, a company developing technology to transform neonatal care, has secured $50 million in Series B funding. The round was led by Sands Capital with participation from Google Ventures (GV), First Spark Ventures, Flerie and Khosla Ventures. The Philadelphia-based company, which emerged from research at Children’s Hospital of Philadelphia (CHOP), is developing a life support system that mimics the womb environment…

Synapticure Raises $25M Series A to Expand Virtual Neurodegenerative Care Platform

Virtual care company Synapticure has secured $25 million in Series A funding to expand its platform providing care for patients with neurodegenerative diseases, a health issue that disproportionately impacts women both as patients and caregivers. The round was led by B Capital, with participation from CommonSpirit Health, CVS Health Ventures, Google Ventures, Optum Ventures, Rock Health Capital, RA Capital Management, and Nexus…

Alloy Raises $16M Series A to Expand Menopause Care Platform

Alloy Women’s Health, a menopause care platform offering telemedicine services and treatment plans, has secured $16 million in Series A funding. The round was led by Kairos HQ, with participation from PACE Healthcare Capital, Emmeline Ventures, and Amboy Street Ventures. The funding announcement comes as Alloy marks its three-year anniversary and achievement of profitability, with the company reporting 300% year-over-year growth in…

Freya Biosciences Receives $10.4M Strategic Investment from Gates Foundation for Women’s Reproductive Health

Freya Biosciences, a biotech company focused on women’s health, has secured a $10.4 million strategic investment from the Bill & Melinda Gates Foundation, along with $1.4 million additional financing from EIFO (Export and Investment Fund of Denmark). The funding extends the company’s Series A to approximately $50 million. The investment will support the expansion of Freya’s DYSCOVERTM platform to develop microbial immunotherapies…

Little Journey Raises £6M Series A to Scale Digital Health Platform Reducing Children’s Hospital Anxiety

Little Journey, a healthtech company providing personalized psychological support for pediatric care, has secured £6 million in Series A funding led by Par Equity, with participation from Mercia Ventures, Northern Powerhouse Investment Fund, Octopus Ventures, Calm/Storm Ventures, and angel investors. “Securing this investment allows us to scale our impact across healthcare and life sciences, with a focus on easing the burden of…